Matt"sBlog

Stratview Research has published a new report on the Age-Related Macular Degeneration Drug  Market, segmented by Aircraft Type (Commercial Aircraft, Regional Aircraft, Military Aircraft, and General Aviation), by Fiber Type (Carbon Fiber Composites and Glass Fiber Composites), by Resin Type (Epoxy Composite and Other Composites). This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global artificial intelligence as a service market. The historic years considered for the study are 2017-2020, base year is 2021, estimated year is 2022, and forecast period is 2023-2027.

Market Highlights

The Age-Related Macular Degeneration Drug Market is projected to grow from USD xx billion in 2020 to USD xx billion by 2026 at a CAGR of around x% during the forecast period.

To know more about the covid impact on the market, click here: https://www.stratviewresearch.com/1871/age-related-macular-degeneration-drug-market.html

 

Covid Impact

Covid-19 has impacted the market dynamics, competition, and global supply chain of every possible market one can think of. The revenues for many, have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operations and strategy will sustain and beat the competition.

Segmentation –

Application Trends

By application, the age-related macular degeneration drug market has been bifurcated into hospitals & clinics, diagnostic centres, and academic research institutes.

• The hospital & clinics segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period.
• The segment growth can be attributed to the presence of established infrastructure and skilled professional healthcare providers.

Regional Trends

By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period.

• The regional growth can be attributed to expanding geriatric populace and presence of key market players such as Regeneron Pharmaceuticals, Inc. (The U.S), and Pfizer Inc. (The U.S).
• The market in Asia-Pacific is expected to be driven by significant growth of the healthcare industry.

Following are the key players in the Age-Related Macular Degeneration Drug  Market:

• Bayer AG (Germany),
• F. Hoffmann-La Roche AG (Switzerland),
• Regeneron Pharmaceuticals, Inc. (The U.S),
• Novartis International AG (Switzerland),
• Bausch Health Companies Inc. (Canada),
• Pfizer Inc. (The U.S),
• Kubota Pharmaceutical (The U.S),
• Ophthotech Corporation (The U.S),
• GlaxoSmithKline PLC (UK),
• Rxi Pharmaceuticals, Inc. (The U.S),
• Alimera Sciences Inc. (The U.S),
• Santen Pharmaceuticals Co. (Japan), and
• Allergan, Inc. (Ireland).

About Stratview Research-

Stratview Research is a global market intelligence firm having a strong team of industry veterans and research analysts. Stratview Research has been serving multiple clients across a wide array of industries. Our services cover a broad spectrum of industries including but not limited to Energy Chemicals, Advanced Materials, Automotive, and Aerospace. At Stratview, we believe in building long term relations with our clients.

Connect with our team here–
https://www.stratviewresearch.com/contact

Or

Call us @: +1-313-307-4176